Published date: 27 November 2020
Last edited date: 16 February 2021
Closed future opportunity - This means that a potential contract has passed its approach to market date. A buyer can choose to consider any supplier interest or convert this notice into an opportunity ready for live procurement.
Contract summary
Industry
Pharmaceutical products - 33600000
Location of contract
England
Value of contract
£35,000,000
Procurement reference
CM/EMP/21/21025
Published date
27 November 2020
Approach to market date
26 February 2021
Contract start date
1 April 2021
Contract end date
31 March 2031
Procedure type
Restricted procedure (above threshold)
A two-stage procedure, where the first stage is used to select suppliers, who are then invited to bid in the second stage.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
The Authority's intention is to establish a dynamic purchasing system (DPS) to purchase antidotes and antibiotics to maintain stockpile of medicines for the use in an emergency.
The products to be included are atropine sulphate injection PFS, oral ciprofloxacin, ciprofloxacin solution for infusion, doxycycline capsules and potassium iodate/iodide tablets. The Authority reserves the right to add/remove products (as and when necessary).
Note that the DPS arrangement shall be valid for a period of 10 years.The value included in this future opportunity is an estimate and will depend on requirements during the life of the DPS.
More information
Spend profile
| Financial year | Budget |
|---|---|
| 2021/2022 | £0 |
About the buyer
Contact name
Lynne Nichols
Address
2nd Floor, Rutland House
Runcorn
WA7 2ES
England
Share this notice
Approach to market date: 26 February 2021
All content is available under the
